Massachusetts Pharmacists Association

04/17/2026

Nearly 62.3% of U.S. adults reported using at least one OTC or prescription medication within a week, reflecting significant reliance on pharmacological therapies and highlighting pharmacists' essential role in managing patient care that integrates self-directed and clinician-guided treatments https://www.drugtopics.com/view/most-us-adults-regularly-use-otc-and-prescription-medication

04/11/2026

04/10/2026

A cross-sectional study of 305 patients with rosacea identified nine factors associated with greater disease severity, including family history, skin care habits, and comorbid conditions. Investigators say recognizing these predictors may help clinicians tailor treatment strategies and guide patients in modifying lifestyle and skin care behaviors to improve outcomes. https://onlinelibrary.wiley.com/doi/10.1111/jocd.70525?prg140729=0d1b0887-ae77-4e42-9ee1-2cf7a7cb4b03

04/08/2026

To help you stay on track, the Board has a detailed overview of all CE requirements, including live, law, collaborative drug therapy management, immunization, and compounding. It also outlines the different duties that require compounding CE, as well as which programs “count” for each type of compounding. https://www.mass.gov/doc/2021-04-continuing-education-ce-requirements-pdf/download

04/07/2026

New research presented at the 2026 American Academy of Orthopaedic Surgeons meeting suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may be associated with increased long-term risk of osteoporosis, gout, and osteomalacia in patients with type 2 diabetes and obesity.https://submissions.mirasmart.com/Verify/AAOS2026/Submission/out/AAOS2026-008736.PDF

04/06/2026

Each year MPhA highlights individuals and organizations who have impacted the profession in Massachusetts. Our awards span the life pharmacists, as well as other members of the pharmacy team. Every pharmacy team has an individual that goes above and beyond and exhibits the highest level of ethics and patient care. It is those individuals who deserve the recognition of these highly regarded awards. Nominations are now open until April 21 for the following awards
Distinguished Young Pharmacists
Excellence in Innovation Award
Bowl of Hygeia
Pharmacy Industry Award
Nathan Goldberg Award
Technician of the Year
Award description and nominations can be found at MPHA Awards Bowl of Hygeia - Massachusetts Pharmacists Association https://masspharmacists.org/content.aspx?page_id=22&club_id=131603&module_id=478844

04/04/2026

The FDA has approved Novo Nordisk’s Sogroya (somapacitan-beco) as the first and only once-weekly, long-acting growth hormone for children 2.5 years and older with three distinct growth disorders: Idiopathic Short Stature (ISS), Noonan Syndrome (NS), and those born Small for Gestational Age (SGA) without catch-up growth. https://skytrofahcp.com/?gad_source=1&gad_campaignid=23557979919&gclid=CjwKCAjwyYPOBhBxEiwAgpT8PyuhF3OK6DXtV3gNxxAvYR7lqHRtfuJKR_OiSOyvgqgAU5-s-T1FyhoChswQAvD_BwE

04/01/2026

Hospital Staff Allegedly Ignored Pharmacist’s Self-diagnosis: https://www.pharmacist.com/Blogs/CEO-Blog/Article/hospital-staff-allegedly-ignored-pharmacists-self-diagnosis